The RACGP has criticised a push for MBS-funded lipoprotein(a) testing to identify patients at elevated risk of heart disease, warning the proposal could be outdated within months due to impending updates to national guidelines.

The Medical Services Advisory Committee (MSAC) is currently considering whether to recommend new MBS items for so-called ‘sticky cholesterol’ tests in patients with a moderate risk of cardiovascular disease (CVD).